series-c-plus
Stage
2
Investors
About
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company developing programmed T-cell therapies, including CAR-T cell therapies, for the treatment of cancer. The company engineers and programs T cells to target hematologic and solid tumor malignancies.
Explore Autolus Therapeutics plc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.